EUVIMEDEUVIMED entdecken
Open Access

Quality by Design Considerations for Drop-on-Demand Point-of-Care Pharmaceutical Manufacturing of Precision Medicine

Thomas P Forbes iD, John Greg Gillen, William Feeney, Johnny Ho

Molecular Pharmaceutics · 01.07.2024 · 21 (7) · 3268-3280

DOI: 10.1021/acs.molpharmaceut.4c00032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 25.04.2024. Verfasst von Thomas P Forbes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Materials Measurement Science Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States. Hauptthemen laut MEDLINE: Precision Medicine, Point-of-Care Systems, Quality Control, Technology, Pharmaceutical. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIST DOC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Distributed and point-of-care (POC) manufacturing facilities enable an agile pharmaceutical production paradigm that can respond to localized needs, providing personalized and precision medicine. These capabilities are critical for narrow therapeutic index drugs and pediatric or geriatric dosing, among other specialized needs. Advanced additive manufacturing, three-dimensional (3D) printing, and drop-on-demand (DoD) dispensing technologies have begun to expand into pharmaceutical production. We employed a quality by design (QbD) approach to identify critical quality attributes (CQAs), critical material attributes (CMAs), and critical process parameters (CPPs) of a POC pharmaceutical manufacturing paradigm. This theoretical framework encompasses the production of active pharmaceutical ingredient (API) "inks" at a centralized facility, which are distributed to POC sites for DoD dispensing into/onto delivery vehicles (e.g., orodispersible films, capsules, single liquid dose vials). Focusing on the POC dispensing/dosing processes, QbD considerations and cause-and-effect analyses identified the dispensed API quantity and solid-state form (CQAs), as well as the nozzle diameter, system pressure channel, and number of drops dispensed (CPPs) for detailed investigation. Final assay quantification and content uniformity CQAs were measured from demonstrative levothyroxine sodium single-dose liquid vials of glycerin/water, meeting the standard acceptance values. Each POC facility is unlikely to maintain full quality control laboratory capabilities, requiring the development of appropriate atline or inline methods to ensure quality control. We developed control strategies, including atline ultraviolet-visible (UV-vis) verification of the API ink prior to dispensing, inline drop counting during dispensing, intermediate atline-dispensed volume checks, and offline batch confirmation by liquid chromatography-tandem mass spectrometry (LC-MS/MS) following production.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicinePoint-of-Care SystemsQuality ControlTechnology, PharmaceuticalHumansPrinting, Three-DimensionalPharmaceutical Preparations

Stichwörter der Autor:innen

drop-on-demanddrug deliverymanufacturingnarrow therapeutic indexpersonalized medicinepharmaceuticspoint-of-care

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • Materials Measurement Science Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States.

ORCID-Profile: Thomas P Forbes

Förderung

  • Intramural NIST DOC

Zitieren

APA

Forbes, T. P., Gillen, J. G., Feeney, W., & Ho, J. (2024). Quality by Design Considerations for Drop-on-Demand Point-of-Care Pharmaceutical Manufacturing of Precision Medicine. Molecular Pharmaceutics, 21(7), 3268-3280. https://doi.org/10.1021/acs.molpharmaceut.4c00032

Vancouver

Forbes TP, Gillen JG, Feeney W, Ho J. Quality by Design Considerations for Drop-on-Demand Point-of-Care Pharmaceutical Manufacturing of Precision Medicine. Molecular Pharmaceutics. 2024;21(7):3268-3280. doi:10.1021/acs.molpharmaceut.4c00032

BibTeX
@article{Forbes2024,
  author = {Forbes, Thomas P and Gillen, John Greg and Feeney, William and Ho, Johnny},
  title = {Quality by Design Considerations for Drop-on-Demand Point-of-Care Pharmaceutical Manufacturing of Precision Medicine},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  volume = {21},
  number = {7},
  pages = {3268--3280},
  doi = {10.1021/acs.molpharmaceut.4c00032}
}
Kostenlos starten →